$DIRV "will present their custom-tailored and proprietary

New Post Public Reply Private Reply Replies (0) Message Board
TradeForProfits
164
$DIRV "will present their custom-tailored and proprietary #Cannabis #industry #surveillance, security, and safety solutions as discussed in their Jan 9th news release - https://finance.yahoo.com/news/directviews-na...html"

https://finance.yahoo.com/news/stock-market-p...00093.html

Stock Market Press Highlights DirectView Holdings, Cannabis Security and Surveillance Specialists, Ahead of Cannabis Conference 2019; Other Companies Discussed Include Tilray, Inc. and Aurora Cannabis Inc.
ACCESSWIRE ACCESSWIRE•March 26, 2019
NEW YORK, NY / ACCESSWIRE / March 26, 2019 / Stock Market Press (SMP) sees a huge boost coming to the cannabis marketplace as the 2019 Cannabis Conference is scheduled for next week (Apr 1-3) with DirectView Holdings, Inc. (OTC PINK: DIRV) showcasing their systems. Additional companies covered in this spotlight include Tilray, Inc. (TLRY) and Aurora Cannabis Inc. (ACB)

DirectView Holdings, Inc. (DIRV) management has booked premium space at Cannabis Conference 2019 where they will present their custom-tailored and proprietary Cannabis industry surveillance, security, and safety solutions as discussed in their Jan 9th news release - https://finance.yahoo.com/news/directviews-na...00130.html

The industry has seen such a massive surge in cultivation, retail and distribution segments that security concerns have been lagging. This is great for DirectView Holdings, Inc. (DIRV) as they have complete solutions from physical to technological security..

"Post-prohibition security, in this new epoch of cannabis commerce at the state level, is decidedly technology-driven and is even more important for owners and managers in the emerging free market for cannabis products. Government compliance, liability, protecting profits, customer and employee safety, and deterring theft are all vital pillars of security within the industry," said Allen St. Pierre, Vice President of Communications for Freedom Leaf

Tilray, Inc. (TLRY) recently announced the closing of an agreement to which Tilray, Inc. (TLRY), through a wholly-owned subsidiary, has acquired all of the issued and outstanding securities of Natura Naturals Holdings Inc., the parent company of a licensed cultivator of cannabis. This brings over 650,000 sq ft of greenhouse cultivation that requires 24/7/365 surveillance and security. We are seeing expansion of cultivation centers all across the USA as well as Canada and along with it a significant increase in demand for security solutions.

Aurora Cannabis Inc. (ACB) a supplier of medical cannabis must keep strict controls over their product to ensure quality is maintained from cultivation to patient delivery. We are seeing security extend, similar to banks, to include delivery via secured vehicles.


"When asked about the 2019 Cannabis Conference, Roger Ralston, CEO and Chairman of DirectView stated, "As we expand our product and service offerings in 2019, it's important that DirectView attends events and keeps shareholders updated. For our Cannabis industry solutions, DirectView made sure to book premium space at the 2019 Cannabis Conference. Many retailers operate entirely on cash, which raises safety concerns. Additionally, there is a risk of fire and explosions when dealing with flammable gasses and liquids in the production of CBD extracts. This creates an environment where top-of-the-line security, surveillance, and safety systems, such as those provided by DirectView, are a prerequisite to doing business in the cannabis space." - DirectView press release

Stock Market Press is a financial news company that delivers up to date stock news, introduces private and public companies to a wide audience of investors, consumers, journalists and the general public via social media and a rapidly expanding network.

Contact:

Stock Market Press
110 Wall St.
New York, NY 10005
info@stockmarketpress.com
https://twitter.com/PressStock

Safe Harbor Statement:

Statements in this news release may be ''forward-looking statements.'' Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions or any other statements relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates and projections about our business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and are likely to, differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release and Stock Market Press undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release.

See Stock Market Press disclaimer: http://stockmarketpress.com/disclaimer/.

SOURCE: Stock Market Press
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 11

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 7

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 7

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 11

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 4

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 10

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 6

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 10

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 5

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading

Top 5 Most Recently Viewed Articles

Bonati Spine Institute Celebrates 42 Years of Impact

Updated Category News Views 8

Legacy of Innovation: Bonati's Distinct Contribution Bonati Spine Institute isn't about resting on laurels; it's about changing the game of spine surgery. When Dr. Alfred Bonati rolled up his sleeves back in 1984 and decided 'enough is enough' with open surgeries and long recovery roads, he wasn't just making noise. He was setting the stage for something...

Continue Reading
Understanding Recent Options Movements for Royal Caribbean

Updated Category News Views 154

Overview of Recent Options Activities for Royal Caribbean Group Recently, there's been some fascinating activity within the options market for Royal Caribbean Group, also known by its ticker symbol RCL. Known for its vast fleet and innovative cruise experiences, Royal Caribbean has made headlines in the financial market due to the increasingly bearish sentiment...

Continue Reading
Sandstorm Gold Sees Historic Growth in Recent Quarter

Updated Category News Views 126

Overview of Sandstorm Gold Ltd. Sandstorm Gold Ltd. is an innovative player in the precious metals sector, known for its unique business model. This company specializes in providing upfront financing to mining operations, allowing them to grow while securing a portion of the mine's production for the life of its operation. Its portfolio consists of approximately 230...

Continue Reading
Woodlands Financial Services Declares Third Quarter Dividend

Updated Category News Views 87

Woodlands Financial Services Company Reports Dividend Announcement In a recent development that is sure to please its investors, Woodlands Financial Services Company (NASDAQ: WDFN) has announced a substantial cash dividend for the third quarter. This decision reflects the company's commitment to returning value to its shareholders, marking a positive step forward in its...

Continue Reading
Broadcom Stock Under Pressure: Insights and Future Outlook

Updated Category News Views 92

Current Trends Affecting Broadcom Stock Broadcom Inc. (NASDAQ: AVGO) has recently experienced a downturn in share prices. As of the latest update, Broadcom shares are trading lower, continuing a downward trend following a cautious outlook issued by the company in the prior week. This decline has raised questions among investors and analysts alike about the future...

Continue Reading